203 related articles for article (PubMed ID: 8613530)
1. Impaired actions of insulin-like growth factor 1 on protein Synthesis and degradation in skeletal muscle of rats with chronic renal failure. Evidence for a postreceptor defect.
Ding H; Gao XL; Hirschberg R; Vadgama JV; Kopple JD
J Clin Invest; 1996 Feb; 97(4):1064-75. PubMed ID: 8613530
[TBL] [Abstract][Full Text] [Related]
2. Effect of prolonged uremia on insulin-like growth factor-I receptor autophosphorylation and tyrosine kinase activity in kidney and muscle.
Tsao T; Fervenza F; Friedlaender M; Chen Y; Rabkin R
Exp Nephrol; 2002; 10(4):285-92. PubMed ID: 12097832
[TBL] [Abstract][Full Text] [Related]
3. Altered physiology and action of insulin-like growth factor 1 in skeletal muscle in chronic renal failure.
Kopple JD; Ding H; Gao XL
Am J Kidney Dis; 1995 Jul; 26(1):248-55. PubMed ID: 7611259
[TBL] [Abstract][Full Text] [Related]
4. [Changes of insulin-like growth factor 1 axis in chronic kidney disease and its role in skeletal muscle atrophy].
Gu LJ; Zhang YY; Wang L; Wang JL; Wang X; Yuan WJ
Zhonghua Yi Xue Za Zhi; 2018 Mar; 98(10):749-754. PubMed ID: 29562399
[No Abstract] [Full Text] [Related]
5. Impaired JAK-STAT signal transduction contributes to growth hormone resistance in chronic uremia.
Schaefer F; Chen Y; Tsao T; Nouri P; Rabkin R
J Clin Invest; 2001 Aug; 108(3):467-75. PubMed ID: 11489940
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of insulin-like growth factor signaling pathways in mammary gland by pure antiestrogen ICI 182,780.
Chan TW; Pollak M; Huynh H
Clin Cancer Res; 2001 Aug; 7(8):2545-54. PubMed ID: 11489838
[TBL] [Abstract][Full Text] [Related]
7. Chronic uremia attenuates growth hormone-induced signal transduction in skeletal muscle.
Sun DF; Zheng Z; Tummala P; Oh J; Schaefer F; Rabkin R
J Am Soc Nephrol; 2004 Oct; 15(10):2630-6. PubMed ID: 15466267
[TBL] [Abstract][Full Text] [Related]
8. Insulin-like growth factor-1 and insulin resistance in skeletal muscles of adult and old rats.
Dardevet D; Sornet C; Attaix D; Baracos VE; Grizard J
Endocrinology; 1994 Mar; 134(3):1475-84. PubMed ID: 8119189
[TBL] [Abstract][Full Text] [Related]
9. Characterization of insulin and insulin-like growth factor-I actions in the bovine luteal cell: regulation of receptor tyrosine kinase activity, phosphatidylinositol-3-kinase, and deoxyribonucleic acid synthesis.
Chakravorty A; Joslyn MI; Davis JS
Endocrinology; 1993 Sep; 133(3):1331-40. PubMed ID: 8396016
[TBL] [Abstract][Full Text] [Related]
10. Alcohol impairs insulin and IGF-I stimulation of S6K1 but not 4E-BP1 in skeletal muscle.
Kumar V; Frost RA; Lang CH
Am J Physiol Endocrinol Metab; 2002 Nov; 283(5):E917-28. PubMed ID: 12376318
[TBL] [Abstract][Full Text] [Related]
11. Growth impairment of primary chondrocyte cells by serum of rats with chronic renal failure.
Mak RH; Chang SL; Pak YK
Exp Mol Med; 2004 Jun; 36(3):243-50. PubMed ID: 15272236
[TBL] [Abstract][Full Text] [Related]
12. Elevated myocardial cytosolic calcium impairs insulin-like growth factor-1-stimulated protein synthesis in chronic renal failure.
Qing DP; Ding H; Vadgama J; Wu YY; Kopple JD
J Am Soc Nephrol; 1999 Jan; 10(1):84-92. PubMed ID: 9890313
[TBL] [Abstract][Full Text] [Related]
13. L-type Ca2+ channel-insulin-like growth factor-1 receptor signaling impairment in aging rat skeletal muscle.
Renganathan M; Sonntag WE; Delbono O
Biochem Biophys Res Commun; 1997 Jun; 235(3):784-9. PubMed ID: 9207239
[TBL] [Abstract][Full Text] [Related]
14. IGF-I stimulates protein synthesis but does not inhibit protein breakdown in muscle from septic rats.
Hobler SC; Williams AB; Fischer JE; Hasselgren PO
Am J Physiol; 1998 Feb; 274(2):R571-6. PubMed ID: 9486320
[TBL] [Abstract][Full Text] [Related]
15. IGF-I binding proteins, IGF-I binding protein mRNA and IGF-I receptor mRNA in rats with acute renal failure given IGF-I.
Bohé J; Ding H; Qing DP; Yoon K; Hirschberg R; Wolfgang GH; Kopple JD
Kidney Int; 1998 Oct; 54(4):1070-82. PubMed ID: 9767523
[TBL] [Abstract][Full Text] [Related]
16. Decreased hepatic insulin-like growth factor (IGF)-I and increased IGF binding protein-1 and -2 gene expression in experimental uremia.
Tönshoff B; Powell DR; Zhao D; Durham SK; Coleman ME; Domené HM; Blum WF; Baxter RC; Moore LC; Kaskel FJ
Endocrinology; 1997 Mar; 138(3):938-46. PubMed ID: 9048593
[TBL] [Abstract][Full Text] [Related]
17. Failure of IGF-1 to affect protein turnover in muscle from growth-retarded neonatal rats.
Frampton RJ; Jonas HA; MacMahon RA; Larkins RG
J Dev Physiol; 1990 Mar; 13(3):125-33. PubMed ID: 2177488
[TBL] [Abstract][Full Text] [Related]
18. Insulin-like growth factor (IGF) binding protein-3 inhibits type 1 IGF receptor activation independently of its IGF binding affinity.
Ricort JM; Binoux M
Endocrinology; 2001 Jan; 142(1):108-13. PubMed ID: 11145572
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin II induces skeletal muscle wasting through enhanced protein degradation and down-regulates autocrine insulin-like growth factor I.
Brink M; Price SR; Chrast J; Bailey JL; Anwar A; Mitch WE; Delafontaine P
Endocrinology; 2001 Apr; 142(4):1489-96. PubMed ID: 11250929
[TBL] [Abstract][Full Text] [Related]
20. Insulin-like growth factor-I (IGF-I), insulin-like growth factor binding proteins (IGFBP) and insulin-like growth factor type I receptor in children with various status of chronic renal failure.
Houang M; Cabrol S; Perin L; Ducos B; Bensman A; Le Bouc Y
Growth Horm IGF Res; 2000 Dec; 10(6):332-41. PubMed ID: 11161964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
